Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:40 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Perampanel in Focal Status Epilepticus
NCT04309721 · Assistance Publique - Hôpitaux de Paris · PHASE3 · terminated · last registry update 2023-12-14 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Lack of inclusion” | – | Registry record, Assistance Publique - Hôpitaux de Paris |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against GRIA4 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2024-10-16Results posted on the registry: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Propranolol + Pindolol (NCT01950520)
- 2024-09-19Also stopped (terminated): The Cleveland Clinic, Phentermine / Topiramate Extended Release Oral Capsule + naltrexone/bupropion extended-release (NCT04531176)
- 2024-08-05Results posted on the registry: Dana-Farber Cancer Institute, Perampanel + Standard of Care (NCT04497142)
- 2024-07-31Results posted on the registry: University of Florida, Fycompa + Fycompa with a boost (NCT05201703)
- 2024-07-31Also stopped (terminated): University of Florida, Fycompa + Fycompa with a boost (NCT05201703)
- 2024-07-22Results posted on the registry: The Cleveland Clinic, Phentermine / Topiramate Extended Release Oral Capsule + naltrexone/bupropion extended-release (NCT04531176)
- 2024-06-18Results posted on the registry: VIVUS LLC, VI-0521 + Phentermine (NCT05215418)
- 2024-06-11Results posted on the registry: Kristin R Hoffman, Topiramate + Placebo (NCT01765218)
- 2024-06-11Also stopped (terminated): Kristin R Hoffman, Topiramate + Placebo (NCT01765218)
- 2024-06-06Results posted on the registry: Kimford Jay Meador, Perampanel 1 week titration + Perampanel 2 week titration (NCT04417907)
- 2024-06-06Also stopped (terminated): Kimford Jay Meador, Perampanel 1 week titration + Perampanel 2 week titration (NCT04417907)
- 2024-04-19Results posted on the registry: Massachusetts General Hospital, Topiramate or Placebo (NCT00606411)
- 2024-04-04Phase 3 first posted: Kafrelsheikh University, Zonisamide 50 MG + Topiramate 50 MG (NCT06347497)
- 2024-02-08Phase 3 first posted: Kafrelsheikh University, Valproic acid + Topiramate 50 MG (NCT06248931)
- 2024-02-06Phase 3 first posted: Kafrelsheikh University, Lacosamide 50 MG + Topiramate 50Mg Tab (NCT06243692)
- 2023-11-18Results posted on the registry: VA Office of Research and Development, topiramate + placebo (NCT03176953)
- 2023-11-14Results posted on the registry: Virginia Commonwealth University, topiramate (NCT02878798)
- 2023-10-26Also stopped (withdrawn): University of Minnesota, Qsymia and lifestyle management therapy (NCT05834062)
- 2023-09-15Results posted on the registry: Eisai Inc., perampanel (NCT02914314)
- 2023-08-18Results posted on the registry: Virginia Commonwealth University, Perampanel + Placebo (NCT02120365)
- 2023-07-24Phase 3 first posted: Lady Hardinge Medical College, Topiramate (NCT05958160)
- 2023-07-18Results posted on the registry: Mayo Clinic, Phentermine-Topiramate + Liraglutide (NCT03374956)
- 2023-07-03Results posted on the registry: Weill Medical College of Cornell University, Perampanel 6 MG (NCT03653741)
- 2023-06-22Results posted on the registry: Mayo Clinic, Anticonvulsant Agent + Perampanel (NCT04650204)
- 2023-06-22Also stopped (terminated): Mayo Clinic, Anticonvulsant Agent + Perampanel (NCT04650204)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision